TPG Capital Asia has picked banks to help prepare an initial public offering of its pathology business in the region that could raise as much as $800 million in Singapore, according to people with knowledge of the matter.

The private equity firm is working with Citigroup Inc. and CIMB Group Holdings Bhd. on the planned first-time share sale of Pathology Asia Holdings Pte, said the people. Credit Suisse Group AG and DBS Group Holdings Ltd. are also working on the offering, they said, asking not to be named as the process is private. A listing in the city-state could take place as soon as the end of this year, the people said.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply


Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook